CROCS INC (CROX) Stock Fundamental Analysis

NASDAQ:CROX • US2270461096

100.04 USD
+3.56 (+3.69%)
At close: Feb 20, 2026
100 USD
-0.04 (-0.04%)
After Hours: 2/20/2026, 8:25:51 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

CROX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 45 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX has an average financial health and profitability rating. CROX may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make CROX a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CROX had positive earnings in the past year.
  • CROX had a positive operating cash flow in the past year.
  • CROX had positive earnings in 4 of the past 5 years.
  • In the past 5 years CROX always reported a positive cash flow from operatings.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B -1.5B

1.2 Ratios

  • CROX has a worse Return On Assets (-1.94%) than 68.89% of its industry peers.
  • CROX has a Return On Equity of -6.28%. This is in the lower half of the industry: CROX underperforms 71.11% of its industry peers.
  • CROX has a better Return On Invested Capital (20.18%) than 88.89% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CROX is significantly above the industry average of 11.64%.
Industry RankSector Rank
ROA -1.94%
ROE -6.28%
ROIC 20.18%
ROA(3y)11.62%
ROA(5y)18.77%
ROE(3y)33.33%
ROE(5y)1062.57%
ROIC(3y)20.49%
ROIC(5y)25.32%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K 4K 5K

1.3 Margins

  • CROX has a Operating Margin of 21.97%. This is amongst the best in the industry. CROX outperforms 93.33% of its industry peers.
  • In the last couple of years the Operating Margin of CROX has grown nicely.
  • The Gross Margin of CROX (58.33%) is better than 73.33% of its industry peers.
  • CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 21.97%
PM (TTM) N/A
GM 58.33%
OM growth 3Y-3.7%
OM growth 5Y4.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.69%
GM growth 5Y1.52%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CROX is creating value.
  • The number of shares outstanding for CROX has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CROX has less shares outstanding
  • The debt/assets ratio for CROX is higher compared to a year ago.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 3.93 indicates that CROX is not in any danger for bankruptcy at the moment.
  • CROX's Altman-Z score of 3.93 is fine compared to the rest of the industry. CROX outperforms 77.78% of its industry peers.
  • The Debt to FCF ratio of CROX is 1.87, which is an excellent value as it means it would take CROX, only 1.87 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CROX (1.87) is better than 82.22% of its industry peers.
  • CROX has a Debt/Equity ratio of 0.95. This is a neutral value indicating CROX is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.95, CROX is not doing good in the industry: 75.56% of the companies in the same industry are doing better.
  • Although CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 1.87
Altman-Z 3.93
ROIC/WACC1.86
WACC10.83%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

2.3 Liquidity

  • A Current Ratio of 1.27 indicates that CROX should not have too much problems paying its short term obligations.
  • The Current ratio of CROX (1.27) is worse than 86.67% of its industry peers.
  • A Quick Ratio of 0.74 indicates that CROX may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.74, CROX is doing worse than 82.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.74
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • CROX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.40%.
  • The Earnings Per Share has been growing by 30.96% on average over the past years. This is a very strong growth
  • Looking at the last year, CROX shows a decrease in Revenue. The Revenue has decreased by -1.50% in the last year.
  • CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.86% yearly.
EPS 1Y (TTM)-5.4%
EPS 3Y4.47%
EPS 5Y30.96%
EPS Q2Q%-9.13%
Revenue 1Y (TTM)-1.5%
Revenue growth 3Y4.36%
Revenue growth 5Y23.86%
Sales Q2Q%-3.25%

3.2 Future

  • CROX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.01% yearly.
  • CROX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.35% yearly.
EPS Next Y-2.04%
EPS Next 2Y0.19%
EPS Next 3Y5.3%
EPS Next 5Y5.01%
Revenue Next Year0.69%
Revenue Next 2Y1.58%
Revenue Next 3Y1.5%
Revenue Next 5Y3.35%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 8.04, the valuation of CROX can be described as reasonable.
  • Based on the Price/Earnings ratio, CROX is valued cheaper than 95.56% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.99. CROX is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 8.21, the valuation of CROX can be described as reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 95.56% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. CROX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.04
Fwd PE 8.21
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CROX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CROX is cheaper than 86.67% of the companies in the same industry.
  • CROX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CROX is cheaper than 91.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.88
EV/EBITDA 6.32
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The decent profitability rating of CROX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.26
EPS Next 2Y0.19%
EPS Next 3Y5.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CROX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CROCS INC

NASDAQ:CROX (2/20/2026, 8:25:51 PM)

After market: 100 -0.04 (-0.04%)

100.04

+3.56 (+3.69%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners99.37%
Inst Owner Change-2.02%
Ins Owners2.89%
Ins Owner Change0.97%
Market Cap5.19B
Revenue(TTM)4.04B
Net Income(TTM)-81.20M
Analysts72.73
Price Target92.99 (-7.05%)
Short Float %12.07%
Short Ratio4.64
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.66%
Min EPS beat(2)18.22%
Max EPS beat(2)21.1%
EPS beat(4)4
Avg EPS beat(4)15.32%
Min EPS beat(4)3.5%
Max EPS beat(4)21.1%
EPS beat(8)8
Avg EPS beat(8)15.96%
EPS beat(12)12
Avg EPS beat(12)14.53%
EPS beat(16)16
Avg EPS beat(16)15.58%
Revenue beat(2)2
Avg Revenue beat(2)1.64%
Min Revenue beat(2)1.48%
Max Revenue beat(2)1.79%
Revenue beat(4)3
Avg Revenue beat(4)0.83%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.79%
Revenue beat(8)5
Avg Revenue beat(8)0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.54%
Revenue beat(16)10
Avg Revenue beat(16)0.77%
PT rev (1m)0%
PT rev (3m)3.86%
EPS NQ rev (1m)0.45%
EPS NQ rev (3m)2.23%
EPS NY rev (1m)0%
EPS NY rev (3m)2.79%
Revenue NQ rev (1m)0.72%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 8.04
Fwd PE 8.21
P/S 1.29
P/FCF 7.88
P/OCF 7.31
P/B 4.02
P/tB N/A
EV/EBITDA 6.32
EPS(TTM)12.44
EY12.44%
EPS(NY)12.19
Fwd EY12.18%
FCF(TTM)12.7
FCFY12.69%
OCF(TTM)13.68
OCFY13.68%
SpS77.82
BVpS24.91
TBVpS-8.4
PEG (NY)N/A
PEG (5Y)0.26
Graham Number83.5
Profitability
Industry RankSector Rank
ROA -1.94%
ROE -6.28%
ROCE 25.55%
ROIC 20.18%
ROICexc 20.97%
ROICexgc 43.42%
OM 21.97%
PM (TTM) N/A
GM 58.33%
FCFM 16.31%
ROA(3y)11.62%
ROA(5y)18.77%
ROE(3y)33.33%
ROE(5y)1062.57%
ROIC(3y)20.49%
ROIC(5y)25.32%
ROICexc(3y)21.34%
ROICexc(5y)28.15%
ROICexgc(3y)55.47%
ROICexgc(5y)57.23%
ROCE(3y)25.94%
ROCE(5y)32.05%
ROICexgc growth 3Y-10.15%
ROICexgc growth 5Y7.53%
ROICexc growth 3Y3.65%
ROICexc growth 5Y-5.95%
OM growth 3Y-3.7%
OM growth 5Y4.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.69%
GM growth 5Y1.52%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 1.87
Debt/EBITDA 1.27
Cap/Depr 64.62%
Cap/Sales 1.27%
Interest Coverage 11.43
Cash Conversion 73.47%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 0.74
Altman-Z 3.93
F-Score5
WACC10.83%
ROIC/WACC1.86
Cap/Depr(3y)125.61%
Cap/Depr(5y)1207.8%
Cap/Sales(3y)1.96%
Cap/Sales(5y)13.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.4%
EPS 3Y4.47%
EPS 5Y30.96%
EPS Q2Q%-9.13%
EPS Next Y-2.04%
EPS Next 2Y0.19%
EPS Next 3Y5.3%
EPS Next 5Y5.01%
Revenue 1Y (TTM)-1.5%
Revenue growth 3Y4.36%
Revenue growth 5Y23.86%
Sales Q2Q%-3.25%
Revenue Next Year0.69%
Revenue Next 2Y1.58%
Revenue Next 3Y1.5%
Revenue Next 5Y3.35%
EBIT growth 1Y-15.14%
EBIT growth 3Y0.5%
EBIT growth 5Y28.92%
EBIT Next Year4.61%
EBIT Next 3Y10.23%
EBIT Next 5Y8.64%
FCF growth 1Y-28.59%
FCF growth 3YN/A
FCF growth 5Y24%
OCF growth 1Y-28.42%
OCF growth 3Y5.61%
OCF growth 5Y21.63%

CROCS INC / CROX FAQ

What is the ChartMill fundamental rating of CROCS INC (CROX) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CROX.


Can you provide the valuation status for CROCS INC?

ChartMill assigns a valuation rating of 7 / 10 to CROCS INC (CROX). This can be considered as Undervalued.


What is the profitability of CROX stock?

CROCS INC (CROX) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CROCS INC?

The Earnings per Share (EPS) of CROCS INC (CROX) is expected to decline by -2.04% in the next year.


Is the dividend of CROCS INC sustainable?

The dividend rating of CROCS INC (CROX) is 0 / 10 and the dividend payout ratio is 0%.